Literature DB >> 16007460

Inhibition of cardiac HERG channels by grapefruit flavonoid naringenin: implications for the influence of dietary compounds on cardiac repolarisation.

Eberhard P Scholz1, Edgar Zitron, Claudia Kiesecker, Sonja Lück, Dierk Thomas, Sven Kathöfer, Volker A W Kreye, Hugo A Katus, Johann Kiehn, Wolfgang Schoels, Christoph A Karle.   

Abstract

Flavonoids are naturally occurring food ingredients that have been associated with reduced cardiovascular mortality in epidemiological studies. In a previous study, we demonstrated for the first time that flavonoids are inhibitors of cardiac human ether-à-go-go-related gene (HERG) channels. Furthermore, we observed that grapefruit juice induced mild QTc prolongation in healthy subjects. HERG blockade by grapefruit flavonoid naringenin is most likely to be the mechanism underlying this effect. Therefore, the electrophysiological properties of HERG blockade by naringenin were analysed in detail. HERG potassium currents expressed in Xenopus oocytes were measured with a two-microelectrode voltage clamp. Naringenin blocked HERG potassium channels with an IC50 value of 102.6 microM in Xenopus oocytes. The onset of blockade was fast. The effect was completely reversible upon wash-out. Naringenin binding to HERG required aromatic residue F656 in the putative pore binding site. Channels were blocked in the open and inactivated states but not in the closed states. Naringenin did not affect HERG current activation. However, the half maximal inactivation voltage was shifted by 14.9 mV towards more negative potentials and current inactivation at negative potentials was accelerated. No frequency dependence of blockade was observed. Naringenin inhibits HERG channels with pharmacological characteristics similar to those of well-known HERG antagonists. From a clinical point of view, this effect could have both proarrhythmic and antiarrhythmic consequences. This may have important implications for phytotherapy and for dietary recommendations for cardiologic patients. Therefore, electrophysiological effects of flavonoids deserve further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007460     DOI: 10.1007/s00210-005-1069-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

Review 1.  Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes.

Authors:  Harry J Witchel; James T Milnes; John S Mitcheson; Jules C Hancox
Journal:  J Pharmacol Toxicol Methods       Date:  2002 Sep-Oct       Impact factor: 1.950

2.  Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations.

Authors:  B N Singh; K Nademanee
Journal:  Am Heart J       Date:  1985-02       Impact factor: 4.749

3.  Tea consumption and mortality after acute myocardial infarction.

Authors:  Kenneth J Mukamal; Malcolm Maclure; James E Muller; Jane B Sherwood; Murray A Mittleman
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

4.  Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women.

Authors:  L Yochum; L H Kushi; K Meyer; A R Folsom
Journal:  Am J Epidemiol       Date:  1999-05-15       Impact factor: 4.897

5.  Relation between intake of flavonoids and risk for coronary heart disease in male health professionals.

Authors:  E B Rimm; M B Katan; A Ascherio; M J Stampfer; W C Willett
Journal:  Ann Intern Med       Date:  1996-09-01       Impact factor: 25.391

6.  A structural basis for drug-induced long QT syndrome.

Authors:  J S Mitcheson; J Chen; M Lin; C Culberson; M C Sanguinetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 7.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

Authors:  E Middleton; C Kandaswami; T C Theoharides
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

8.  Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel.

Authors:  B D Walker; C B Singleton; H Tie; J A Bursill; K R Wyse; S M Valenzuela; S N Breit; T J Campbell
Journal:  Cardiovasc Res       Date:  2000-10       Impact factor: 10.787

Review 9.  The antiarrhythmic drug BRL-32872.

Authors:  Christoph A Karle; Dierk Thomas; Johann Kiehn
Journal:  Cardiovasc Drug Rev       Date:  2002

10.  Bertosamil blocks HERG potassium channels in their open and inactivated states.

Authors:  Edgar Zitron; Christoph A Karle; Gunnar Wendt-Nordahl; Sven Kathöfer; Wei Zhang; Dierk Thomas; Slawomir Weretka; Johann Kiehn
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

View more
  14 in total

1.  Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.

Authors:  Claudia Kiesecker; Markus Alter; Sven Kathöfer; Edgar Zitron; Eberhard P Scholz; Dierk Thomas; Jörg Kreuzer; Hugo A Katus; Alexander Bauer; Christoph A Karle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-12       Impact factor: 3.000

2.  Synergic effects of β-estradiol and erythromycin on hERG currents.

Authors:  Fumiaki Ando; Akinori Kuruma; Seiko Kawano
Journal:  J Membr Biol       Date:  2011-04-12       Impact factor: 1.843

3.  Modulatory Effect of Selected Dietary Phytochemicals on Delayed Rectifier K+ Current in Human Prostate Cancer Cells.

Authors:  Kiran George; Nisha Susan Thomas; Raman Malathi
Journal:  J Membr Biol       Date:  2019-06-04       Impact factor: 1.843

Review 4.  Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.

Authors:  András Varró; István Baczkó
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

5.  Identifying regulators for EAG1 channels with a novel electrophysiology and tryptophan fluorescence based screen.

Authors:  Tinatin I Brelidze; Anne E Carlson; Douglas R Davies; Lance J Stewart; William N Zagotta
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

6.  Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: block attenuation by mutations of the pore residues Y652 or F656.

Authors:  Eberhard P Scholz; Franziska M Konrad; Daniel L Weiss; Edgar Zitron; Claudia Kiesecker; Ramona Bloehs; Martin Kulzer; Dierk Thomas; Sven Kathöfer; Alexander Bauer; Martin H Maurer; Gunnar Seemann; Hugo A Katus; Christoph A Karle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-27       Impact factor: 3.000

7.  Acute and subacute effects of the selective serotonin-noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels.

Authors:  F Fischer; N Vonderlin; C Seyler; E Zitron; B Schernus; H Katus; E Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-05-12       Impact factor: 3.000

8.  Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents.

Authors:  Daniel Scherer; David Hassel; Ramona Bloehs; Edgar Zitron; Katharina von Löwenstern; Claudia Seyler; Dierk Thomas; Franziska Konrad; Heiner F Bürgers; Gunnar Seemann; Wolfgang Rottbauer; Hugo A Katus; Christoph A Karle; Eberhard P Scholz
Journal:  Br J Pharmacol       Date:  2009-01-16       Impact factor: 8.739

9.  Ability of naringenin, a bioflavonoid, to activate M-type potassium current in motor neuron-like cells and to increase BKCa-channel activity in HEK293T cells transfected with α-hSlo subunit.

Authors:  Hung-Te Hsu; Yu-Ting Tseng; Yi-Ching Lo; Sheng-Nan Wu
Journal:  BMC Neurosci       Date:  2014-12-24       Impact factor: 3.288

10.  Differential effects of ginsenoside metabolites on HERG k channel currents.

Authors:  Sun-Hye Choi; Tae-Joon Shin; Sung-Hee Hwang; Byung-Hwan Lee; Jiyeon Kang; Hyeon-Joong Kim; Jae-Wook Oh; Chun Sik Bae; Soo-Han Lee; Seung-Yeol Nah
Journal:  J Ginseng Res       Date:  2011-06       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.